When your mood feels flat, anxious, or unlike yourself, it makes sense to question anything new you are taking. The 2022 review found no eligible trials of CBD for mood disorders. The studies do give you a clearer picture of what has been measured, which products are different from one another, and when a label or medication list needs a closer look.
What have human CBD studies actually found about mood?
A 2022 psychiatric CBD review included 16 randomized or within-subject studies: six in psychotic disorders, three in anxiety disorders, six across substance-use disorders, and one in insomnia. The authors described CBD as generally safe and well tolerated within those studies.
The closest mood experiment in the evidence was a 2024 CBD-THC trial in 31 healthy adults aged 21 to 58. Over a two-week protocol, each participant received a single 1 mL sublingual dose containing 100 mg CBD and 5 mg THC in one study period and placebo in another. About 2.5 hours after dosing, contentedness and amicability scores increased versus placebo; 23% reported drowsiness or sedation between three and six hours. This was a medical cannabis oil, not a gummy, and it included THC.
CBD is one cannabinoid from cannabis. A 2021 preclinical review describes its low affinity for cannabinoid receptors and its activity across several brain-signalling systems, including anandamide, serotonin 1A, and TRPV receptors. That biology helps explain why mood questions are being studied; it is not a shortcut from a brain mechanism to a result you should expect from a gummy. For a closer look at claims often made around anxious feelings, see CBD gummy anxiety claims.
Which effects have been reported with gummies or oral cannabinoid products?
| Study | People and timing | Product and amount | What it reported |
|---|---|---|---|
| 2024 CBD-THC trial | 31 healthy adults; two-week crossover protocol | One 1 mL sublingual dose: 100 mg CBD plus 5 mg THC | Higher contentedness and amicability at about 2.5 hours; 23% reported drowsiness or sedation from three to six hours. |
| 2025 gummy case report | One 26-year-old man | 40 mg CBD gummies | Nausea, vomiting, heart rate rising from 80 to 165 bpm, a conduction change on ECG, and raised lactate; symptoms resolved with supportive care. |
The 2025 report is a single case, so it is a reason to take severe symptoms seriously rather than a prediction of what will happen to every person. The NHLBI adverse-event guidance explains that an event occurring after an exposure is not, by timing alone, a determination that the exposure caused it.
For the questions people often type into search—nightmares, headaches or migraines, stomach problems, diarrhoea, constipation, dry mouth, indigestion, nausea, insomnia, panic, palpitations, memory changes, weight changes, blood pressure, cancer, seizures, and heart problems—the useful next step is to match the exact product label and your medication list with a clinician or pharmacist before buying. The case report above specifically involved nausea, vomiting, and a marked fast heart rate; the healthy-volunteer trial specifically recorded drowsiness and selected memory-task changes.
What does the gummy label tell you?
Start with the cannabinoid panel, not the front-of-pack promise. A CBD drug-testing guide describes full-spectrum products as retaining cannabinoids and terpenes, including THC; broad-spectrum products as formulated without THC; and CBD isolate as CBD alone. Those are product categories, so the per-gummy amount, serving size, and batch report still matter.
For comparison, the oral amounts in the studies here were 40 mg in the gummy case report and 100 mg CBD plus 5 mg THC in the one-dose medical-cannabis oil study. A retail gummy’s label should let you identify the CBD amount per gummy, the suggested serving, whether THC is present, and a batch-specific cannabinoid report.
Can CBD gummies interact with common medicines?
They can matter if you use medicines processed through liver enzyme systems. CED Clinic identifies particular concern with blood thinner warfarin, seizure medicine phenytoin, and other medicines with a narrow safety margin; its explanation of CBD drug interactions is a useful starting point. Bring the exact gummy label, amount per gummy, and every prescription and nonprescription medicine to a clinician or pharmacist before you add CBD.
That conversation is especially important if you use seizure medicine. This CBD medicine review identifies Epidiolex as the only FDA-approved CBD medicine and names Dravet syndrome and Lennox-Gastaut syndrome as its approved seizure-disorder uses. A retail gummy is a different product and should not be treated as interchangeable with it. For the practical reason timing can change an interaction question, read CBD enzyme interactions.
Could a CBD gummy affect a drug test?
Yes—trace THC is the key concern. Standard workplace panels commonly look for THC metabolites rather than CBD itself, and full-spectrum CBD may contain THC. A batch report can help you see the cannabinoid content, but it cannot promise a result on a future test. If a test has high stakes for your work, licence, or legal situation, confirm the testing policy and discuss the product with the testing program before using it.
If you are trying to understand what a study registration can and cannot tell you about CBD, the site’s guide to CBD trial results separates a registered protocol from published findings.
What should you check before buying CBD gummies?
- Whether the package says full-spectrum, broad-spectrum, or isolate.
- The CBD and THC amount per gummy and per suggested serving.
- A batch-specific cannabinoid report that matches the product in your hand.
- Your medicines, especially warfarin, phenytoin, and other prescriptions that need close dose control.
- Whether a drug test could affect a job, programme, licence, or legal matter.
- The seller’s return terms before placing an order; this CBD seller terms comparison explains the terms worth reading.
Where does that leave you?
If you are comparing products, the site’s Golden Touch Fusion CBD Gummies reviews cover that product’s buyer questions without making it the answer for every CBD shopper. Choose based on the actual label, your medicines, and whether THC exposure would create a problem for you.
By the Global MH Summit Research Team
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.